Ozempic vs Wegovy — What's the Difference?

Join host Julia Cartwright as she unravels the mystery behind Ozempic and Wegovy—two brand names, one molecule, but totally different purposes. Discover the crucial differences in dosing, insurance coverage, clinical trial results, and what doctors really consider before prescribing these GLP-1 medications.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Host Julia Cartwright examines clinical trial data comparing Ozempic and Wegovy, both containing semaglutide but approved for different uses. She discusses the landmark STEP-1 trial showing 14.9% weight loss with Wegovy, cardiovascular benefits documented in 2024 FDA approval, and why dose differences matter for A1C reductions and long-term treatment expectations.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Join host Julia Cartwright as she unpacks why doctors prescribe Ozempic versus Wegovy—same drug, wildly different paths. This episode explores insurance barriers, BMI thresholds, off-label prescribing, and the hidden decisions shaping your semaglutide prescription. Learn how to navigate prior authorizations, understand dosing differences, and advocate for yourself in a system that treats diabetes differently than obesity.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Julia Cartwright breaks down why Ozempic and Wegovy—identical semaglutide molecules—have different names, doses, and FDA approvals. She explains how one targets diabetes at 2mg weekly while the other tackles weight loss at 2.4mg, exploring clinical trials, regulatory pathways, and what it means for patients navigating these groundbreaking treatments.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.